E-LIB Suche - Ergebnisse für: Gaidano, G

1

Exploring artificial intelligence techniques for morphologi..:

Sacchetti, S. ; Bellia, M. ; Vidali, M....
Clinica Chimica Acta. 558 (2024) - p. 118809 , 2024

Link: https://doi.org/10.1016/..

2

Radioimmunotherapy versus autologous hematopoietic stem cel..:

Ladetto, M. ; Tavarozzi, R. ; Zanni, M....
Annals of Oncology. 35 (2024) 1 - p. 118-129 , 2024

Link: https://doi.org/10.1016/..

3

Five‐year subgroup analysis of tafasitamab + lenalidomide f..:

Duell, J. ; Abrisqueta, P. ; Dreyling, M....
Hematological Oncology. 41 (2023) S2 - p. 439-441 , 2023

Link: https://doi.org/10.1002/..

4

CUMULATIVE RADIATION DOSES IN LYMPHOMA PATIENTS FROM DIAGNO..:

Matheoud, R. ; Siciliano, C. ; Cannillo, B....
Physica Medica. 115 (2023) - p. 102861 , 2023

Link: https://doi.org/10.1016/..

5

SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN P..:

Stathis, A. ; Hitz, F. ; Schär, S....
Hematological Oncology. 41 (2023) S2 - p. 165-166 , 2023

Link: https://doi.org/10.1002/..

6

EFFICACY AND SAFETY OF MOLTO, A MULTICENTER, OPEN LABEL, PH..:

Frustaci, A. M. ; Montillo, M. ; Rossi, D....
Hematological Oncology. 41 (2023) S2 - p. 62-63 , 2023

Link: https://doi.org/10.1002/..

7

Five‐year efficacy and safety of tafasitamab in patients wi..:

Duell, J. ; Abrisqueta, P. ; Andre, M....
Hematological Oncology. 41 (2023) S2 - p. 437-439 , 2023

Link: https://doi.org/10.1002/..

8

CUMULATIVE RADIATION DOSES IN LYMPHOMA PATIENTS FROM DIAGNO..:

D'Alessio, A. ; Matheoud, R. ; Siciliano, C....
Physica Medica. 115 (2023) - p. 102860 , 2023

Link: https://doi.org/10.1016/..

9

P1281: LIQUID BIOPSY PROVIDES COMPLEMENTARY INFORMATION TO ..:

Moia, R. ; Favini, C. ; Talotta, D....
HemaSphere. 6 (2022) - p. 1166-1167 , 2022

Link: https://doi.org/10.1097/..

10

P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DR..:

Daver, N. G. ; Montesinos, P. ; Aribi, A....
HemaSphere. 6 (2022) - p. 454-455 , 2022

Link: https://doi.org/10.1097/..

11

P1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERT..:

Alessandria, B. ; Genuardi, E. ; Civita, A. M....
HemaSphere. 6 (2022) - p. 1130-1131 , 2022

Link: https://doi.org/10.1097/..

12

S221: BORTEZOMIB TO R-DHAP COMPARED TO R-DHAP IN RELAPSED/R..:

Chiappella, A. ; Balzarotti, M. ; Botto, B...
HemaSphere. 6 (2022) - p. 122-123 , 2022

Link: https://doi.org/10.1097/..

13

S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY ("3 +..:

Lübbert, M. ; Wijermans, P. ; Kicinski, M....
HemaSphere. 6 (2022) - p. 26-27 , 2022

Link: https://doi.org/10.1097/..

14

P1144: RADIOIMMUNOTHERAPY (RIT) VERSUS AUTOLOGOUS HEMATOPOI..:

Ladetto, M. ; Tavarozzi, R. ; Evangelista, A....
HemaSphere. 6 (2022) - p. 1032-1033 , 2022

Link: https://doi.org/10.1097/..

15

A COMPLETELY GENETIC PROGNOSTIC MODEL OVERCOMES CLINICAL PR..:

Ferrero, S. ; Moia, R. ; Cascione, L....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..